Physician

Sarah Mirocha, M.D.

According to 2025 Medicare claims, Sarah Mirocha, M.D. (NPI: 1356405054) practices endocrinology in the Sheboygan, WI market, with the plurality of this provider's patient population coming from Sheboygan, WI. This provider's primary affiliated billing organization is ST. NICHOLAS HOSPITAL-SISTERS OF THE THIRD ORDER OF ST FRANCIS (NPI: 1275799413; TIN: 390808480) and primary practice location at 53081-1948. Mirocha is affiliated with the HSHS ACO, L.L.C. (ACO ID: A2783), participating under the MSSP model.

Mirocha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 209 traditional Medicare patients, billed 17,590 HCPCS/CPT codes, and received $191,634 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,602 prescription claims across 321 beneficiaries totaling $1,270,627 in drug costs, led by Ozempic (Semaglutide). DME data shows 222 claims. Open Payments data shows 14 records totaling $288. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $22,119 to $191,634. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $493,923 to $1,270,627. For DME billing, reported payments rose steadily, from $5,905 to $92,187.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$96K$192K2015 Medicare payment: $22,119 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $24,279 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $27,340 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $30,161 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $37,119 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $33,231 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $176,052 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $155,603 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $67,309 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $191,634 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015141330$22,119
2016164375$24,279
2017176419$27,340
2018194715$30,161
2019190918$37,119
2020174912$33,231
20211741,739$176,052
20221551,625$155,603
20231854,152$67,309
202420917,590$191,634

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$784K$1.6M2015 Drug cost: $493,923 (USD; Tot_Drug_Cst)2016 Drug cost: $694,225 (USD; Tot_Drug_Cst)2017 Drug cost: $837,572 (USD; Tot_Drug_Cst)2018 Drug cost: $871,225 (USD; Tot_Drug_Cst)2019 Drug cost: $1,036,719 (USD; Tot_Drug_Cst)2020 Drug cost: $1,129,482 (USD; Tot_Drug_Cst)2021 Drug cost: $1,396,223 (USD; Tot_Drug_Cst)2022 Drug cost: $1,447,953 (USD; Tot_Drug_Cst)2023 Drug cost: $1,567,134 (USD; Tot_Drug_Cst)2024 Drug cost: $1,270,627 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151671,437$493,923
20162061,821$694,225
20172281,993$837,572
20182501,938$871,225
20192532,010$1,036,719
20202682,281$1,129,482
20212802,411$1,396,223
20222762,424$1,447,953
20233052,566$1,567,134
20243212,602$1,270,627

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$43K$87K2015 Medicare payment: $12,088 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $11,327 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $16,993 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $39,086 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $56,442 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $86,926 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $75,344 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $73,671 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $72,624 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $83,640 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201557248$12,088
201663220$11,327
201780289$16,993
201871321$39,086
201984371$56,442
202098489$86,926
202177462$75,344
202254423$73,671
202362394$72,624
202454222$83,640

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4242$106
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more137189$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5459$60
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's108142$12
83036Hemoglobin a1c level4270$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide1519,034$301,076
Humulin R U-500 KwikpenInsulin Regular, Human613,115$136,468
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7554,325$101,513
TrulicityDulaglutide582,184$75,469
ForteoTeriparatide18510$74,490

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4239Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceN41193$82,981
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsN1329$659

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$288Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sarah Mirocha, M.D.?

Tedicare shows public-source Medicare data for Sarah Mirocha, M.D. (NPI 1356405054), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Mirocha, M.D. have ACO affiliation data?

Sarah Mirocha, M.D. is shown with ACO affiliation data for HSHS ACO, L.L.C. (MSSP, ACO ID A2783).

What billing organization is linked to Sarah Mirocha, M.D.?

Sarah Mirocha, M.D. is linked to ST. NICHOLAS HOSPITAL-SISTERS OF THE THIRD ORDER OF ST FRANCIS (billing NPI 1275799413) in the available physician profile data.

Does Sarah Mirocha, M.D. have Open Payments data?

Sarah Mirocha, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.